Different antivascular endothelial growth factor (VEGF) monotherapy regimens and photodynamic therapy (PDT) combined with anti-VEGF therapy are available for patients with polypoidal choroidal vasculopathy (PCV). The gene discussed is VEGFA; the disease is Polypoidal choroidal vasculopathy.